{"gene":"PTMA","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":2025,"finding":"PTMA interacts with MBD3, inhibiting its deacetylation activity within the MBD3/HDAC1 NuRD complex. This inhibition increases STAT3 acetylation, which in turn promotes STAT3 phosphorylation and activation of its target genes, thereby driving cardiomyocyte proliferation.","method":"Co-immunoprecipitation, conditional knockout in cardiomyocytes, AAV9-mediated overexpression, overexpression in primary mouse/rat and human iPSC-derived cardiomyocytes with proliferation readouts","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, KO, OE, epistasis), replicated across species (mouse, rat, human iPSC), with defined molecular mechanism and cellular phenotype","pmids":["40408476"],"is_preprint":false},{"year":2025,"finding":"PTMA functions as a linker histone chaperone that promotes release of histone H1.0 from chromatin at sites of DNA damage, and is required for efficient recruitment of PARP1 to damaged DNA. PTMA-null (Ptma-/-) cells show impaired H1.0 exit from damaged chromatin and fail to efficiently recruit PARP1, resulting in increased sensitivity to DNA-damaging agents.","method":"Photoconvertible fluorescent protein tagging of H1.0 with live-cell imaging, stable Ptma-/- cell lines (homozygous null), Parp1-/- cells, overexpression of H1.0 mutant with tight chromatin binding, DNA damage sensitivity assays","journal":"Epigenetics & chromatin","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal approaches (live imaging, genetic KO, overexpression of dominant mutant) in single study with clearly defined mechanism","pmids":["40474236"],"is_preprint":false},{"year":2026,"finding":"PTMA preserves mitochondrial DNA integrity in CD8 T cells through direct interaction with mitochondrial transcription factor A (TFAM), sustaining oxidative phosphorylation under metabolic stress. PTMA expression in T cells is transcriptionally controlled by TCF1. Genetic deletion of Ptma from T cells impairs CD8 T cell persistence in tumors and abolishes the therapeutic effect of PD-1 blockade.","method":"Genetic deletion of Ptma in T cells, transcriptome analysis, protein interaction studies (PTMA-TFAM), metabolic assays (oxidative phosphorylation), in vivo tumor models with PD-1 blockade","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with defined phenotype, protein–protein interaction, functional metabolic readout, and in vivo therapeutic epistasis, all in single study","pmids":["41544148"],"is_preprint":false},{"year":2023,"finding":"PTMA binds to HMGB1 (detected by co-immunoprecipitation and immunofluorescence). Knockdown of PTMA in ESCC cells inhibits mitochondrial oxidative phosphorylation, induces ROS accumulation, and increases apoptosis; overexpression of HMGB1 rescues these effects, indicating that PTMA–HMGB1 interaction regulates mitochondrial oxidative phosphorylation.","method":"Co-immunoprecipitation, immunofluorescence, siRNA knockdown, HMGB1 overexpression rescue, ROS assay (DCFH-DA), MitoSOX, JC-1, mitochondrial complex activity assays, Western blot","journal":"Journal of thoracic disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP plus functional rescue with HMGB1 overexpression, multiple mitochondrial readouts, single lab","pmids":["37065565"],"is_preprint":false},{"year":2017,"finding":"In a TGFβ1-induced fibrosis model of primary human oral submucous fibroblasts, PTMA knockdown reverses TGFβ1-induced fibrosis by inhibiting fibroblast proliferation and reducing Collagen I, α-SMA, and MMP9 protein levels while increasing SMAD4 levels; PTMA overexpression enhances TGFβ1-induced fibrosis. This places PTMA downstream of TGFβ1 and upstream of SMAD4-mediated ECM regulation.","method":"siRNA knockdown and overexpression in primary human oral submucous fibroblasts, CCK-8 proliferation assay, Western blot for ECM markers, TGFβ1-induced fibrosis model","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss- and gain-of-function in primary human cells with multiple molecular readouts, single lab","pmids":["29088825"],"is_preprint":false},{"year":2021,"finding":"Macrophage-derived PTMA induces hyphal filamentation in Candida albicans. Bioactivity-guided fractionation coupled to mass spectrometry identified PTMA as the active component; immunoneutralization of PTMA within macrophage lysate abolished its filamentation-inducing activity, and enzymatic treatment implicated phosphorylated protein as responsible.","method":"Bioactivity-guided fractionation, mass spectrometry, immunoneutralization with anti-PTMA antibody, enzymatic treatment of lysate, C. albicans filamentation assay","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — immunoneutralization plus biochemical fractionation/MS identification, orthogonal enzyme treatment, single lab","pmids":["34433036"],"is_preprint":false}],"current_model":"PTMA (Prothymosin α) is a multifunctional nuclear/cytoplasmic protein that acts as a linker histone (H1) chaperone to promote chromatin decompaction and PARP1 recruitment at DNA damage sites; interacts with MBD3 to inhibit HDAC1-containing NuRD complex deacetylase activity, thereby increasing STAT3 acetylation and phosphorylation to drive cardiomyocyte proliferation and heart regeneration; binds TFAM to maintain mitochondrial DNA integrity and sustain oxidative phosphorylation in CD8 T cells; binds HMGB1 to regulate mitochondrial oxidative phosphorylation in cancer cells; and acts downstream of TGFβ1/SMAD4 signaling to modulate fibroblast ECM production."},"narrative":{"mechanistic_narrative":"PTMA (Prothymosin α) is a multifunctional, intrinsically charged nuclear and cytoplasmic protein that operates as a chromatin/chaperone factor and a regulator of mitochondrial and transcriptional programs across diverse cell types [PMID:40408476, PMID:40474236, PMID:41544148]. In the nucleus, PTMA acts as a linker histone chaperone that promotes release of histone H1.0 from chromatin at sites of DNA damage and is required for efficient PARP1 recruitment, with PTMA-null cells failing to evict H1.0 and showing heightened sensitivity to DNA-damaging agents [PMID:40474236]. PTMA also tunes chromatin-associated transcriptional output by binding MBD3 and inhibiting the deacetylase activity of the MBD3/HDAC1 NuRD complex, thereby raising STAT3 acetylation and phosphorylation to drive cardiomyocyte proliferation [PMID:40408476]. In the mitochondrial/metabolic axis, PTMA binds the mitochondrial transcription factor TFAM to preserve mitochondrial DNA integrity and sustain oxidative phosphorylation in CD8 T cells—a function placed downstream of TCF1 and required for T cell persistence and the efficacy of PD-1 blockade [PMID:41544148]—and engages HMGB1 to support oxidative phosphorylation and restrain ROS accumulation and apoptosis in esophageal cancer cells [PMID:37065565]. PTMA additionally acts downstream of TGFβ1 to modulate fibroblast proliferation and SMAD4-associated ECM production [PMID:29088825], and macrophage-derived phosphorylated PTMA can induce hyphal filamentation in Candida albicans [PMID:34433036].","teleology":[{"year":2017,"claim":"Established PTMA as a functional node in TGFβ1-driven fibrosis, addressing whether PTMA actively contributes to ECM production rather than being a passive marker.","evidence":"siRNA knockdown and overexpression in primary human oral submucous fibroblasts with proliferation and ECM marker readouts in a TGFβ1-induced fibrosis model","pmids":["29088825"],"confidence":"Medium","gaps":["Direct molecular mechanism linking PTMA to SMAD4 not defined","Single lab, single primary cell type","No physical interaction with a TGFβ pathway component shown"]},{"year":2021,"claim":"Showed that secreted/macrophage-derived phosphorylated PTMA has an extracellular bioactivity, identifying it as a host factor that drives Candida albicans hyphal filamentation.","evidence":"Bioactivity-guided fractionation with mass spectrometry, immunoneutralization, and enzymatic treatment in a C. albicans filamentation assay","pmids":["34433036"],"confidence":"Medium","gaps":["Fungal receptor or target of PTMA unidentified","Phosphosite responsible for activity not mapped","Physiological relevance in vivo not established"]},{"year":2023,"claim":"Defined a PTMA–HMGB1 interaction controlling mitochondrial oxidative phosphorylation, linking PTMA to redox and apoptotic balance in cancer cells.","evidence":"Reciprocal co-IP, immunofluorescence, siRNA knockdown with HMGB1 overexpression rescue, and multiple mitochondrial/ROS assays in ESCC cells","pmids":["37065565"],"confidence":"Medium","gaps":["Mechanism by which the PTMA–HMGB1 complex regulates OXPHOS unresolved","Subcellular site of interaction not localized","Single lab"]},{"year":2025,"claim":"Resolved a nuclear mechanism for PTMA as a linker histone chaperone, answering how H1.0 is displaced from damaged chromatin to permit PARP1 recruitment.","evidence":"Photoconvertible H1.0 live-cell imaging, Ptma-/- and Parp1-/- cells, dominant tight-binding H1.0 mutant, and DNA damage sensitivity assays","pmids":["40474236"],"confidence":"High","gaps":["Structural basis of PTMA–H1.0 chaperoning not solved","Whether PTMA acts directly on H1 variants beyond H1.0 untested","Order/coupling of H1 release and PARP1 loading not fully dissected"]},{"year":2025,"claim":"Connected PTMA to a chromatin-modifying transcriptional circuit, showing it inhibits NuRD deacetylase activity via MBD3 to amplify STAT3 signaling and drive cardiomyocyte proliferation.","evidence":"Co-IP, cardiomyocyte conditional knockout, AAV9 overexpression, and epistasis across mouse, rat, and human iPSC-derived cardiomyocytes","pmids":["40408476"],"confidence":"High","gaps":["How PTMA binding inhibits HDAC1 catalysis mechanistically unclear","Whether the NuRD-STAT3 axis operates outside cardiomyocytes untested"]},{"year":2026,"claim":"Identified a mitochondrial genome-protective role for PTMA via TFAM that sustains CD8 T cell oxidative metabolism and immunotherapy response, placing it downstream of TCF1.","evidence":"T cell-specific Ptma deletion, transcriptomics, PTMA-TFAM interaction studies, OXPHOS assays, and in vivo tumor models with PD-1 blockade","pmids":["41544148"],"confidence":"High","gaps":["Structural/biochemical basis of PTMA–TFAM interaction not defined","How a predominantly nuclear protein accesses the mitochondrial matrix unresolved","Relationship between this TFAM role and the HMGB1-OXPHOS role unexplored"]},{"year":null,"claim":"How PTMA's distinct nuclear (H1.0/NuRD) and mitochondrial (TFAM/HMGB1) activities are coordinated, and what governs its partitioning between compartments and partners, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying structural model across binding partners","Determinants of subcellular targeting unknown","Post-translational regulation (e.g., phosphorylation) linking functions uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[1]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[1]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[2,3]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[1]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,3]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2]}],"complexes":[],"partners":["MBD3","HDAC1","TFAM","HMGB1","H1.0","PARP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P06454","full_name":"Prothymosin alpha","aliases":[],"length_aa":111,"mass_kda":12.2,"function":"Prothymosin alpha may mediate immune function by conferring resistance to certain opportunistic infections","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P06454/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/PTMA","classification":"Common Essential","n_dependent_lines":735,"n_total_lines":1208,"dependency_fraction":0.6084437086092715},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000187514","cell_line_id":"CID001263","localizations":[{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"RPS27A","stoichiometry":10.0},{"gene":"SRP9;DKFZP564M2223","stoichiometry":4.0},{"gene":"INPPL1","stoichiometry":0.2},{"gene":"KEAP1","stoichiometry":0.2},{"gene":"MKI67","stoichiometry":0.2},{"gene":"KPNA1","stoichiometry":0.2},{"gene":"ELMSAN1","stoichiometry":0.2},{"gene":"MRPL3","stoichiometry":0.2},{"gene":"SRP14","stoichiometry":0.2},{"gene":"CCDC137","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001263","total_profiled":1310},"omim":[{"mim_id":"614663","title":"RALY HETEROGENEOUS NUCLEAR RIBONUCLEAR PROTEIN; RALY","url":"https://www.omim.org/entry/614663"},{"mim_id":"612428","title":"RNA-BINDING MOTIF PROTEIN 38; RBM38","url":"https://www.omim.org/entry/612428"},{"mim_id":"600832","title":"ACIDIC NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER A; ANP32A","url":"https://www.omim.org/entry/600832"},{"mim_id":"188390","title":"PROTHYMOSIN, ALPHA; PTMA","url":"https://www.omim.org/entry/188390"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PTMA"},"hgnc":{"alias_symbol":[],"prev_symbol":["TMSA"]},"alphafold":{"accession":"P06454","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P06454","model_url":"https://alphafold.ebi.ac.uk/files/AF-P06454-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P06454-F1-predicted_aligned_error_v6.png","plddt_mean":58.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PTMA","jax_strain_url":"https://www.jax.org/strain/search?query=PTMA"},"sequence":{"accession":"P06454","fasta_url":"https://rest.uniprot.org/uniprotkb/P06454.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P06454/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P06454"}},"corpus_meta":[{"pmid":"31960446","id":"PMC_31960446","title":"Circular RNA hsa_circ_0004277 contributes to malignant phenotype of colorectal cancer by sponging miR-512-5p to upregulate the expression of PTMA.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31960446","citation_count":34,"is_preprint":false},{"pmid":"30988666","id":"PMC_30988666","title":"Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB).","date":"2019","source":"Clinical proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/30988666","citation_count":32,"is_preprint":false},{"pmid":"36968197","id":"PMC_36968197","title":"The simultaneous administration of microplastics and cadmium alters rat testicular activity and changes the expression of PTMA, DAAM1 and PREP.","date":"2023","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/36968197","citation_count":25,"is_preprint":false},{"pmid":"34433036","id":"PMC_34433036","title":"The macrophage-derived protein PTMA induces filamentation of the human fungal pathogen Candida albicans.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34433036","citation_count":16,"is_preprint":false},{"pmid":"29088825","id":"PMC_29088825","title":"PTMA, a new identified autoantigen for oral submucous fibrosis, regulates oral submucous fibroblast proliferation and extracellular matrix.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29088825","citation_count":9,"is_preprint":false},{"pmid":"40408476","id":"PMC_40408476","title":"PTMA controls cardiomyocyte proliferation and cardiac repair by enhancing STAT3 acetylation.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/40408476","citation_count":8,"is_preprint":false},{"pmid":"37414786","id":"PMC_37414786","title":"Multimodal investigation of electronic transport in PTMA and its impact on organic radical battery performance.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37414786","citation_count":8,"is_preprint":false},{"pmid":"37065565","id":"PMC_37065565","title":"PTMA binds to HMGB1 to regulate mitochondrial oxidative phosphorylation and thus affect the malignant progression of esophageal squamous cell carcinoma.","date":"2023","source":"Journal of thoracic disease","url":"https://pubmed.ncbi.nlm.nih.gov/37065565","citation_count":5,"is_preprint":false},{"pmid":"40474236","id":"PMC_40474236","title":"The linker histone chaperone Prothymosin α (PTMA) is essential for efficient DNA damage repair and the recruitment of PARP1.","date":"2025","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/40474236","citation_count":4,"is_preprint":false},{"pmid":"37852614","id":"PMC_37852614","title":"Practical Cell Design for PTMA-Based Organic Batteries: an Experimental and Modeling Study.","date":"2023","source":"ACS applied materials & interfaces","url":"https://pubmed.ncbi.nlm.nih.gov/37852614","citation_count":3,"is_preprint":false},{"pmid":"41544148","id":"PMC_41544148","title":"PTMA safeguards mitochondrial integrity to sustain metabolic function and antitumor activity of CD8 T cells.","date":"2026","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41544148","citation_count":1,"is_preprint":false},{"pmid":"40629240","id":"PMC_40629240","title":"The Complicity of DAAM1, PTMA, RSPH6A, and Steroidogenic Genes in the Fertility of Male Rats Exposed to Cadmium During Gestation and Lactation: Attenuation by PREOG.","date":"2025","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/40629240","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8290,"output_tokens":1845,"usd":0.026273,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8767,"output_tokens":2883,"usd":0.057955,"stage2_stop_reason":"end_turn"},"total_usd":0.084228,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2025,\n      \"finding\": \"PTMA interacts with MBD3, inhibiting its deacetylation activity within the MBD3/HDAC1 NuRD complex. This inhibition increases STAT3 acetylation, which in turn promotes STAT3 phosphorylation and activation of its target genes, thereby driving cardiomyocyte proliferation.\",\n      \"method\": \"Co-immunoprecipitation, conditional knockout in cardiomyocytes, AAV9-mediated overexpression, overexpression in primary mouse/rat and human iPSC-derived cardiomyocytes with proliferation readouts\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, KO, OE, epistasis), replicated across species (mouse, rat, human iPSC), with defined molecular mechanism and cellular phenotype\",\n      \"pmids\": [\"40408476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PTMA functions as a linker histone chaperone that promotes release of histone H1.0 from chromatin at sites of DNA damage, and is required for efficient recruitment of PARP1 to damaged DNA. PTMA-null (Ptma-/-) cells show impaired H1.0 exit from damaged chromatin and fail to efficiently recruit PARP1, resulting in increased sensitivity to DNA-damaging agents.\",\n      \"method\": \"Photoconvertible fluorescent protein tagging of H1.0 with live-cell imaging, stable Ptma-/- cell lines (homozygous null), Parp1-/- cells, overexpression of H1.0 mutant with tight chromatin binding, DNA damage sensitivity assays\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal approaches (live imaging, genetic KO, overexpression of dominant mutant) in single study with clearly defined mechanism\",\n      \"pmids\": [\"40474236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"PTMA preserves mitochondrial DNA integrity in CD8 T cells through direct interaction with mitochondrial transcription factor A (TFAM), sustaining oxidative phosphorylation under metabolic stress. PTMA expression in T cells is transcriptionally controlled by TCF1. Genetic deletion of Ptma from T cells impairs CD8 T cell persistence in tumors and abolishes the therapeutic effect of PD-1 blockade.\",\n      \"method\": \"Genetic deletion of Ptma in T cells, transcriptome analysis, protein interaction studies (PTMA-TFAM), metabolic assays (oxidative phosphorylation), in vivo tumor models with PD-1 blockade\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with defined phenotype, protein–protein interaction, functional metabolic readout, and in vivo therapeutic epistasis, all in single study\",\n      \"pmids\": [\"41544148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PTMA binds to HMGB1 (detected by co-immunoprecipitation and immunofluorescence). Knockdown of PTMA in ESCC cells inhibits mitochondrial oxidative phosphorylation, induces ROS accumulation, and increases apoptosis; overexpression of HMGB1 rescues these effects, indicating that PTMA–HMGB1 interaction regulates mitochondrial oxidative phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence, siRNA knockdown, HMGB1 overexpression rescue, ROS assay (DCFH-DA), MitoSOX, JC-1, mitochondrial complex activity assays, Western blot\",\n      \"journal\": \"Journal of thoracic disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP plus functional rescue with HMGB1 overexpression, multiple mitochondrial readouts, single lab\",\n      \"pmids\": [\"37065565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In a TGFβ1-induced fibrosis model of primary human oral submucous fibroblasts, PTMA knockdown reverses TGFβ1-induced fibrosis by inhibiting fibroblast proliferation and reducing Collagen I, α-SMA, and MMP9 protein levels while increasing SMAD4 levels; PTMA overexpression enhances TGFβ1-induced fibrosis. This places PTMA downstream of TGFβ1 and upstream of SMAD4-mediated ECM regulation.\",\n      \"method\": \"siRNA knockdown and overexpression in primary human oral submucous fibroblasts, CCK-8 proliferation assay, Western blot for ECM markers, TGFβ1-induced fibrosis model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss- and gain-of-function in primary human cells with multiple molecular readouts, single lab\",\n      \"pmids\": [\"29088825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Macrophage-derived PTMA induces hyphal filamentation in Candida albicans. Bioactivity-guided fractionation coupled to mass spectrometry identified PTMA as the active component; immunoneutralization of PTMA within macrophage lysate abolished its filamentation-inducing activity, and enzymatic treatment implicated phosphorylated protein as responsible.\",\n      \"method\": \"Bioactivity-guided fractionation, mass spectrometry, immunoneutralization with anti-PTMA antibody, enzymatic treatment of lysate, C. albicans filamentation assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — immunoneutralization plus biochemical fractionation/MS identification, orthogonal enzyme treatment, single lab\",\n      \"pmids\": [\"34433036\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PTMA (Prothymosin α) is a multifunctional nuclear/cytoplasmic protein that acts as a linker histone (H1) chaperone to promote chromatin decompaction and PARP1 recruitment at DNA damage sites; interacts with MBD3 to inhibit HDAC1-containing NuRD complex deacetylase activity, thereby increasing STAT3 acetylation and phosphorylation to drive cardiomyocyte proliferation and heart regeneration; binds TFAM to maintain mitochondrial DNA integrity and sustain oxidative phosphorylation in CD8 T cells; binds HMGB1 to regulate mitochondrial oxidative phosphorylation in cancer cells; and acts downstream of TGFβ1/SMAD4 signaling to modulate fibroblast ECM production.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PTMA (Prothymosin α) is a multifunctional, intrinsically charged nuclear and cytoplasmic protein that operates as a chromatin/chaperone factor and a regulator of mitochondrial and transcriptional programs across diverse cell types [#0, #1, #2]. In the nucleus, PTMA acts as a linker histone chaperone that promotes release of histone H1.0 from chromatin at sites of DNA damage and is required for efficient PARP1 recruitment, with PTMA-null cells failing to evict H1.0 and showing heightened sensitivity to DNA-damaging agents [#1]. PTMA also tunes chromatin-associated transcriptional output by binding MBD3 and inhibiting the deacetylase activity of the MBD3/HDAC1 NuRD complex, thereby raising STAT3 acetylation and phosphorylation to drive cardiomyocyte proliferation [#0]. In the mitochondrial/metabolic axis, PTMA binds the mitochondrial transcription factor TFAM to preserve mitochondrial DNA integrity and sustain oxidative phosphorylation in CD8 T cells—a function placed downstream of TCF1 and required for T cell persistence and the efficacy of PD-1 blockade [#2]—and engages HMGB1 to support oxidative phosphorylation and restrain ROS accumulation and apoptosis in esophageal cancer cells [#3]. PTMA additionally acts downstream of TGFβ1 to modulate fibroblast proliferation and SMAD4-associated ECM production [#4], and macrophage-derived phosphorylated PTMA can induce hyphal filamentation in Candida albicans [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 2017,\n      \"claim\": \"Established PTMA as a functional node in TGFβ1-driven fibrosis, addressing whether PTMA actively contributes to ECM production rather than being a passive marker.\",\n      \"evidence\": \"siRNA knockdown and overexpression in primary human oral submucous fibroblasts with proliferation and ECM marker readouts in a TGFβ1-induced fibrosis model\",\n      \"pmids\": [\"29088825\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct molecular mechanism linking PTMA to SMAD4 not defined\", \"Single lab, single primary cell type\", \"No physical interaction with a TGFβ pathway component shown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed that secreted/macrophage-derived phosphorylated PTMA has an extracellular bioactivity, identifying it as a host factor that drives Candida albicans hyphal filamentation.\",\n      \"evidence\": \"Bioactivity-guided fractionation with mass spectrometry, immunoneutralization, and enzymatic treatment in a C. albicans filamentation assay\",\n      \"pmids\": [\"34433036\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Fungal receptor or target of PTMA unidentified\", \"Phosphosite responsible for activity not mapped\", \"Physiological relevance in vivo not established\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined a PTMA–HMGB1 interaction controlling mitochondrial oxidative phosphorylation, linking PTMA to redox and apoptotic balance in cancer cells.\",\n      \"evidence\": \"Reciprocal co-IP, immunofluorescence, siRNA knockdown with HMGB1 overexpression rescue, and multiple mitochondrial/ROS assays in ESCC cells\",\n      \"pmids\": [\"37065565\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism by which the PTMA–HMGB1 complex regulates OXPHOS unresolved\", \"Subcellular site of interaction not localized\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Resolved a nuclear mechanism for PTMA as a linker histone chaperone, answering how H1.0 is displaced from damaged chromatin to permit PARP1 recruitment.\",\n      \"evidence\": \"Photoconvertible H1.0 live-cell imaging, Ptma-/- and Parp1-/- cells, dominant tight-binding H1.0 mutant, and DNA damage sensitivity assays\",\n      \"pmids\": [\"40474236\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Structural basis of PTMA–H1.0 chaperoning not solved\", \"Whether PTMA acts directly on H1 variants beyond H1.0 untested\", \"Order/coupling of H1 release and PARP1 loading not fully dissected\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected PTMA to a chromatin-modifying transcriptional circuit, showing it inhibits NuRD deacetylase activity via MBD3 to amplify STAT3 signaling and drive cardiomyocyte proliferation.\",\n      \"evidence\": \"Co-IP, cardiomyocyte conditional knockout, AAV9 overexpression, and epistasis across mouse, rat, and human iPSC-derived cardiomyocytes\",\n      \"pmids\": [\"40408476\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"How PTMA binding inhibits HDAC1 catalysis mechanistically unclear\", \"Whether the NuRD-STAT3 axis operates outside cardiomyocytes untested\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identified a mitochondrial genome-protective role for PTMA via TFAM that sustains CD8 T cell oxidative metabolism and immunotherapy response, placing it downstream of TCF1.\",\n      \"evidence\": \"T cell-specific Ptma deletion, transcriptomics, PTMA-TFAM interaction studies, OXPHOS assays, and in vivo tumor models with PD-1 blockade\",\n      \"pmids\": [\"41544148\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Structural/biochemical basis of PTMA–TFAM interaction not defined\", \"How a predominantly nuclear protein accesses the mitochondrial matrix unresolved\", \"Relationship between this TFAM role and the HMGB1-OXPHOS role unexplored\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PTMA's distinct nuclear (H1.0/NuRD) and mitochondrial (TFAM/HMGB1) activities are coordinated, and what governs its partitioning between compartments and partners, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No unifying structural model across binding partners\", \"Determinants of subcellular targeting unknown\", \"Post-translational regulation (e.g., phosphorylation) linking functions uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"MBD3\", \"HDAC1\", \"TFAM\", \"HMGB1\", \"H1.0\", \"PARP1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}